Welcome to our dedicated page for Corsair Partnering news (Ticker: CORS), a resource for investors and traders seeking the latest updates and insights on Corsair Partnering stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Corsair Partnering's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Corsair Partnering's position in the market.
Corsair Partnering Corporation announced the successful closing of its initial public offering of 25,000,000 units, priced at $10.00 each. This offering, which began trading on the NYSE under the ticker 'CORS.U' on July 1, 2021, includes Class A ordinary shares and warrants. The company aims to engage in partnering transactions, focusing on prominent financial service firms. Additionally, Corsair Capital LLC has committed to purchase up to 10,000,000 units for $100 million in a private placement linked to its initial partnership. The SEC has declared a registration statement effective.
Corsair Partnering Corporation has priced its initial public offering (IPO) at $10.00 per unit, raising up to $250 million. The offering consists of 25 million units, expected to be listed on the NYSE under the ticker symbol CORS.U starting July 1, 2021. Each unit includes one Class A ordinary share and one-third of a redeemable warrant, with whole warrants exercisable at $11.50 per share. The underwriters, Evercore Group and BofA Securities, have a 45-day option to purchase an additional 3.75 million units. The offering is set to close on July 6, 2021.